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SUMMARY
Background: Nonsteroidal anti-inflammatory drugs such as aspirin (ASA) are known to induce gastric mucosal
damage including bleeding, ulceration and perforation in humans and experimental animals. These adverse ef-
fects of ASA were originally attributed to the inhibition of cyclooxygenase and the deficiency of endogenous pro-
staglandins induced by this drug but the role of reactive oxygen species (ROS), lipid peroxidation and antioxidi-
zing mechanism in the pathogenesis of ASA damage has been little studied. New class of nitric oxide (NO)-rele-
asing nonsteroidal anti-inflammatory drugs was shown to inhibit cyclooxygenase and prostaglandin generation
without causing mucosal damage but it remains unknown whether these agents affect the healing process of
chronic gastric ulcers. 
Material and Methods: In this study the effect of NO-releasing aspirin (NO-ASA) and was compared with that
of native aspirin applied with or without vitamin C on the healing of acetic acid ulcers. The area of gastric ulcer
was determined by planimetry, the gastric blood flow (GBF) at ulcer margin was measured by H2 gas clearance
method and mucosal release of ROS was quantified by measuring the chemiluminescence before and after the
treatment with ASA or NO-ASA alone and ASA combined with vitamin C. The plasma antiinflammatory cyto-
kine such as IL-1b and oxygen radical-mediated lipid peroxidation was measured in the ulcerated gastric mu-
cosa of ASA and NO-ASA-treated animals. 
Results: ASA delayed significantly ulcer healing and this effect was accompanied by a marked increase in the
chemiluminescence, lipid peroxidation and the fall in the GBF at ulcer margin. Vitamin C attenuated signifi-
cantly both the ASA-induced gastric damage and accompanying fall in the GBF at ulcer margin and the rise in
the chemiluminescence and reversed the ASA-induced lipid peroxidation. In contrast, NO-ASA failed to affect
healing of gastric ulcers and failed to produce the rise in the plasma IL-1b levels and the increase of lipid pero-
xidation as compared to those recorded in ASA-treated animals. 
Conclusions: 1) ROS-induced enhancement in lipid peroxidation plays an important role in the mechanism of
gastric damage induced by ASA, 2) vitamin C attenuates the deleterious effect of ASA on ulcer healing due to
its antioxidizing activity by mechanism involving preservation of gastric microcirculation and attenuation of li-
pid peroxidation and cytokine release and 3) coupling of NO to aspirin fails to delay the ulcer healing sugge-
sting that NO might compensate for prostaglandin deficiency induced by NSAID.
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BACKGROUND
Non-steroidal anti-inflammatory drugs (NSAID)
such as aspirin (ASA) are widely used but the major
limitation of their clinical application are serious
gastrointestinal side-effects, such as aggravation of
stress-induced gastric damage and interference
with the healing of gastric ulcerations [1—3]. Recen-
tly, a new class of NSAID has been developed by
adding of nitric oxide (NO) moiety to the native
NSAID [4—10]. The rationale behind this strategy is
that NO released from these derivatives exerts be-
neficial influence on gastric mucosa by enhancing
the mucosal defensive ability and preventing pa-
thogenic events resulting from suppression of pro-
stanoid synthesis such as the reduction in gastric
microcirculation and the leukocyte-endothelial ad-
herence [11—13]. Earlier studies revealed that en-
dogenous NO released from vascular endothelium,
sensory nerves or gastric epithelial cells cooperates
with prostaglandins in the maintenance of gastric
mucosa integrity and microcirculation [14,15].
In contrast to native NSAID, their NO-releasing de-
rivatives such as NO-aspirin (NO-ASA) [4,12,20]
were found to exhibit lower gastric toxicity despite
inhibiting both COX-1 and COX-2 activity in the
gastric mucosa [20]. The major importance of NO
in the prevention of mucosal damage or in prese-
rvation of ulcer healing is supported by previous
studies showing that both endogenous NO rele-
ased by capsaicin [15] or exogenous NO origina-
ting from L-arginine, a NO-synthase or glyceryl tri-
nitrate exert gastroprotective activity and accelera-
te healing mainly by the maintenance of blood
flow around the ulcer and angiogenesis [16,17].
The present study was designed; 1) to compare the
effect of topical application of ASA and its NO-de-
rivative on ulcer healing and gastric blood flow at
ulcer margin; 2) to determine the role of ROS me-
asured by the chemiluminescence in rats with ga-
stric ulcer treated with ASA; and 3) to elucidate the
lipid peroxidation, which is associated with induc-
tion of cellular oxidative stress. Since vitamin C is
known to exert potent antioxidizing activity, we
determined whether ASA-induced damage and the
accompanying release of ROS is affected by the
concurrent treatment with vitamin C.
MATERIAL AND METHODS
Male Wistar rats, weighing 180—220 g and fasted
for 24 h before the study were employed in all stu-
dies.
Production of gastric ulcers
Gastric ulcers were produced in 150 fasted rats,
using our modification [17] of acetic acid method
originally proposed by Okabe et al [19]. With the
animals under ether anesthesia, the stomach was
exposed and 75 µl of acetic acid was poured thro-
ugh the plastic mold (6 mm diameter) onto serosal
surface of anterior wall of the stomach just proxi-
mal to the antral gland area for 25 sec. This produ-
ced immediate necrosis of the entire mucosa and
submucosa within the area where the acetic acid
was applied, i.e, about 28 mm2. The excess of ace-
tic acid was then removed and the serosa was gen-
tly washed with tap saline. Our previous studies
documented that these ulcers become chronic wi-
thin 2—3 days and heal completely within 2—3 we-
eks without perforation or penetration to the surro-
unding organs as described in original Oka-
beÕs technique [19]. After the application of acetic
acid the animals were allowed to recover from
anesthesia and received only water on the day of
operation (Day 0). Then, they were divided into
various groups and received normal chow and wa-
ter ad libitum for the next 3, 9 and 15 days. To
evaluate the effects of native ASA and their NO-re-
leasing derivative, the animals were anesthetized
with ether and the abdomen was opened and the
stomach was exposed to assess the GBF at ulcer
margin, ulcer crater and in the contralateral intact
mucosa using H2-gas clearance technique as de-
scribed before [16,17]. The stomach was then re-
moved and pinned open for the determination of
the area of gastric ulcers by planimetry (Morpho-
mat, Carl Zeiss, Berlin, German) by two investiga-
tors under blinded conditions. The half of the sto-
mach with gastric ulcer in rats with or without ad-
ministration of vehicle (control), ASA or NO-ASA
was taken during autopsy and immediately fixed in
10% formalin, embedded in paraffin and stained
with hematoxylin and eosin for the histological as-
sessment of the quality of ulcer healing. Coded
specimens of mucosa stained with hematoxylin
and eosin were evaluated at 260x magnification
under blinded conditions.
Experimental groups and treatments
Several group of animals each consisting of 6—8
rats were used to determine the effect of the treat-
ment with vehicle, ASA (50 mg/kg — d i.g.) with or
without vitamin C (0.5 g/kg — d i.g.) and its NO-de-
rivative NO-ASA (50 mg/kg — d i.g.) on the healing
of gastric ulcers induced by the serosal application
of acetic acid (ulcer area 28 mm2). The NO-ASA
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(NCX 4016 batch 3) was a generous gift of Mrs.
Nathalie Baundry (NicOx, Valbonne, France). The
animals were killed at 0, 3, 9 and 15 days after
ulcer induction and the area of gastric ulcerations
was determined by planimetry, the GBF was me-
asured by H2-gas clearance method as mentioned
above and the gastric luminal NO—2/NO
—
3 content
was assessed by Griess technique. Venous blood
from vena cava was collected for the assessment of
plasma IL-1b levels and biopsy samples were taken
for determination of generation of PGE2 by RIA
and measurement of lipid peroxidation.
Measurement of chemiluminescence
Biopsy samples were taken from the non-ulcerated
and ulcerated gastric mucosa (about 1 mm from
the ulcer crater) for the measurement of lucigenin-
-amplified chemiluminescence. Each specimen
was immediately washed in phosphate-buffered
saline containing 5 mmol/l of glucose (pH 7.4) and
transferred to a dark adapted scintillation vial con-
taining 1 ml of lucigenin employed in a concentra-
tion of 400 mmol/L. All solutions were pre-oxyge-
nated prior to use. Chemiluminescence was me-
asured over 8 minutes in a LKB Wallac B scintilla-
tion counter (model 1409) operating in Ôout of
coincidenceÕ mode. Specimens were then carefully
blotted dry and weighed and chemiluminescence
expressed as counts per minute per gram of tissue
(cpm/g).
Determination of PGE2 generation in gastric mu-
cosa and luminal NO release
For ex vivo determination of PGE2, the mucosa was
processed, according to the method described pre-
viously [2]. Briefly, a portion of corpus mucosa
(about 100 mg) excised from rats treated with ve-
hicle, acidified ASA and NO-ASA was placed in an
Eppendorf plastic tube containing 1.0 ml of 10 mM
phosphate buffer (pH 7.4) and minced with fine
scissors for 15 seconds. The samples were then in-
cubated in a shaking bath (37¡C) for 20 minutes
and then centrifuged 30 sec at 9000 g. The super-
natant was collected and frozen at —20¡C for sub-
sequent determination of PGE2 using radioimmu-
noassay (PGE2-RIA kit, Amersham, Munich, Ger-
many).
For the measurement of NO generation, 1 ml of
saline was introduced to the stomach and the lumi-
nal content was collected for the determination of
total NO—3/NO
—
2 concentration using commercially
available kit purchased from Cayman (Ann Arbor,
MI, USA) as described previously [10]. This method
is based on the Griess reaction and generation of
chromophore absorbing at 595 nm, according to
the original procedure described previously [10].
Since NO released by epithelial cells into the ga-
stric lumen is quickly transformed into NO3
— and
NO2
— [20], we measured photometrically the sum
of both these products of NOS as an index of pro-
duction of NO by the enzyme in the gastric muco-
sa. For this purpose, the gastric content was aspira-
ted just before the removal of the stomach follo-
wing the i.g. injection of 1 ml of saline to wash out
the luminal content. After centrifugation for 10 min
at 3000 rpm, the samples were mixed with Griess
reagent from the commercially available kit. In all
tests including those with ASA, NO-ASA and ASA
combined with vitamin C, the GBF was measured
in the oxyntic mucosa in each group of animals in
similar manner as mentioned before and expressed
as the percent control value recorded in vehicle-
-treated gastric mucosa.
Determination of plasma IL-1b levels and lipid
peroxidation in gastric mucosa
Immediately after measurement of GBF, a venous
blood sample was withdrawn from the vena cava
into the EDTA containing vials and used either for
the determination of plasma IL-1b concentrations
by specific ELISA assay according to the manufac-
turerÕs recommendation (Endogen Inc, Cambridge,
MA, USA).
Since lipid peroxidation is a well-established me-
chanism of cellular injury induced by reactive oxy-
gen metabolites, we measured the changes in the
malondialdehyde (MDA) as an indicator of the li-
pid peroxidation in gastric mucosa treated with ve-
hicle, ASA alone or combined with vitamin C and
that treated with NO-ASA. For the measurement of
lipid peroxidation, the tissue was weighed, trans-
ferred to the ice-cooled test tube and homogeni-
zed in 400 ml of 20 mM Tris buffer pH=7.4 conta-
ining 5 mM butylated hydroxytoluene to prevent
new lipid peroxidation that can occur during the
homogenization. The homogenate was then centri-
fuged at 4¡C for 10 min and resulted supernatant
(200 ml) was stored in —80¡C until an assay of lipid
peroxidation (BIOXYTECH LPO-assay kit, OXIS In-
ternational Inc. Portland, USA). The content of li-
pid peroxidation was measured at 37¡C by spectro-
photometer at wave length of 586 nm and compa-
red with the absorbance of purified MDA as the
standard. The results are expressed as the amount
of MDA in the gastric mucosa of rats treated with
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ASA with or without the combination with vitamin
C and after 9 days treatment with NO-ASA as com-
pared to vehicle-control animals.
Statistical analysis
Results are expressed as means–SEM. The signifi-
cance of the difference between means was evalu-
ated using analysis of variance followed by Dun-
canÕs test or, when appropriate, by WilcoxonÕs rank
sum test with a level of confidence at P<0.05.
RESULTS
Effect of vehicle, native ASA with or without com-
bination with vitamin C and NO-releasing ASA on
the area of gastric ulcers and accompanying chan-
ges in gastric blood flow (GBF) at ulcer margin
and plasma IL-1b levels
Figure 1 shows the time-course of ulcer healing in
rats with administration of vehicle or ASA (50
mg/kg — d i.g.), NO-ASA (50 mg/kg — d i.g.) and
ASA combined with vitamin C (0.5 g/kg — d i.g.) on
the area of gastric ulcers at 0, 3, 9 and 15 days
upon ulcer induction. In rats treated with vehicle,
a significant reduction in the area of these ulcers
was observed from initial size of about 28 mm2 to
23.8–4.3 mm2, 16.2–3.1 mm2 and 10.9–2.5
mm2 at day 3, 9 and 15 upon ulcer induction, re-
spectively. Native ASA failed to affect significantly
the area of gastric ulcers at day 3 upon ulcer in-
duction but prolonged significantly ulcer healing at
day 9 and day 15 upon ulcer induction. In con-
trast, NO-ASA and vitamin C added to this ASA
tended to accelerate the ulcer healing though this
change failed to reach statistical significance.
The GBF in the non-ulcerated antro-oxyntic muco-
sa of rats treated with vehicle averaged 46 ml/min
—100 g (taken as 100%) being significantly reduced
by about 15% at the ulcer margin at day 9, when
compared to that in the contralateral intact mucosa
(data not shown). At day 9 upon ulcer induction,
the native ASA delayed significantly ulcer healing
and this was accompanied by the significant decre-
ase in the GBF at ulcer margin and the significant
rise in the plasma IL-1b levels as compared to the
respective values in vehicle-treated gastric mucosa
(Fig. 2). Treatment with NO-ASA resulted in a si-
gnificant decrease in ulcer area and plasma IL-1b
increments as compared to the respective values
obtained in native ASA-treated animals and raised
the GBF at ulcer margin to the extent not signifi-
cantly different than that in vehicle-control gastric
mucosa. When vitamin C was added to native
ASA, a significant reduction in the area of gastric
ulcers and plasma IL-1b levels accompanied by the
increase in the GBF at ulcer margin was observed
as compared to those in native ASA-treated ani-
mals (Fig. 2).
Effect of vehicle, native ASA with or without the
combination with vitamin C and NO-releasing
ASA on the lucigenin-induced chemiluminescen-
ce, lipid peroxidation, PGE2 generation and lumi-
nal NO content
The results with the chemiluminescence in the ve-
hicle-control mucosa as well as in those exposed to
ASA alone and ASA combined with vitamin C or
treated with NO-ASA are presented in Table 1. The
lucigenin-dependent chemiluminescence was signi-
ficantly amplified in ASA-treated mucosa as compa-
red to that obtained in vehicle-treated animals. In
contrast, co-administration of vitamin C with ASA
reversed completely the rise in the chemilumine-
scence induced by ASA alone. NO-ASA failed to in-
fluence significantly the chemiluminescence as
compared to that recorded in the gastric mucosa of
rats treated with native ASA (Table 1).
Figure 1. Chemical structures of native acetylsalicylic acid (aspirin,
ASA) and nitric oxide (NO)-releasing ASA (acetylsalicylic
acid 4-(nitroxy) butylester).
Fig. 3 shows the changes in the mucosal MDA plus
4-HNE content, measured as an index of lipid pe-
roxidation, in the gastric mucosa of animals treated
with vehicle and those treated with ASA without or
with concurrent vitamin C administration or expo-
sed to NO-ASA. In ASA-treated animals, a signifi-
cant rise in the MDA was observed as compared to
the value obtained in vehicle-control animals. The
addition of vitamin C to ASA attenuated significan-
tly mucosal MDA plus 4-HNE content, which re-
ached the value not significantly different from that
recorded in vehicle-treated mucosa. In contrast to
native ASA, the treatment with NO-ASA failed to
affect the significantly the mucosal MDA plus 4-
-HNE content, which reached the value not signifi-
cantly different from that recorded in vehicle-
-treated mucosa.
The PGE2 generation in the ulcerated gastric mu-
cosa and the NO concentration in the gastric con-
tent in rats treated with vehicle averaged 116–8
ng/g wet tissue weight and 3.1–0.4 mmol/l, respec-
tively, at day 15 upon ulcer induction (Table 1).
ASA and NO-ASA inhibited mucosal PGE2 synthe-
sis in the ulcerated gastric mucosa with the extent
similar to that in NO-ASA treated gastric mucosa.
The ulcer healing effect of NO-ASA was accompa-
nied by a significant rise in GBF and NO concen-
tration in the gastric content as compared to those
treated with native ASA (Fig. 2, Table 1). Mucosal
content of PGE2 was also suppressed in rats treated
with NO-ASA, despite the fact that NO-ASA was
found to improve the ulcer healing as compared to
native ASA. (Table 1, Figs. 1 and 2).
DISCUSSION
Our study demonstrates that ASA damages the rat
gastric mucosa and that this effect is accompanied
by the enhancement in the ROS determined by
means of chemiluminescence assay. Furthermore,
we found that ASA increased mucosal MDA con-
tent in the gastric mucosa suggesting that this rise
in the lipid peroxidation possible due to the acti-
vation of neutrophils as proposed originally [21],
play an important role in the damaging activity of
this NSAID. This increase in the neutrophil media-
ted-lipid peroxidation was suppressed by NO-rele-
asing ASA and by the addition of vitamin C to na-
tive ASA, suggesting that this mechanism of new
generation of so called ÔsafeÕ NSAID, namely NO-
-NSAID or NSAID combined with vitamin C may
counteract the deleterious effect of classic NSAID
on the gastric mucosa. This is supported by the
fact that following the ulcer healing, the GBF was
elevated and luminal NO production was enhan-
ced in animals treated with NO-releasing ASA as
compared to those treated with native ASA. Thus,
our study implies that native NSAID delay ulcer
healing but NO-NSAID fail to impair ulcer healing
possibly due to excessive release of NO that may
compensate for PG deficiency induced by these
NSAIDs.
ROS were originally implicated in the gastric injury
provoked in experimental animals using various
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Figure 2. Mean area of gastric ulcers in rats treated throughout a
period of 3—15 days with vehicle (VEH), acidified aspirin
(ASA, 50 mg/kg — d i.g.), ASA combined with vitamin C (0.5
g/kg i.g.) or nitric oxide (NO)-releasing ASA (50 mg/kg — d
i.g.). Mean–SEM of 6—8 rats. Asterisk indicates significant
change as compared to the value obtained immediately upon
ulcer induction (day 0). Cross indicates significant change
as compared to the value obtained in vehicle-treated
animals.
Type of test PGE2 generation(ng/g wet tissue)
Luminal NO
(µmol/L)
Chemiluminescen
ce CLM
(cpm x 1000/g)
Vehicle
ASA
NO-ASA
ASA + vitamin C
116–8
35–4*
41–3*
43–4*
3.1–0.4
2.6–0.2
16.4–4.5*
3.8–0.7
5.4–0.3
15.6–0.8*
6.3–0.6+
5.9–0.4+
Table 1. Effect of vehicle,  acidified aspirin (ASA, 50 mg/kg-d i.g.) with
or without the combination with vitamin C (0.5 g/kg-d i.g.)
and the treatment with NO-ASA (50 mg/kg-d i.g.) on the
mucosal generation of PGE2 in the ulcerated gastric mucosa,
the luminal NO production and chemiluminescence (CLM) in
gastric mucosa of rats with gastric ulcers at day 15 upon
ulcer induction. Results are mean – SEM of 8—10 rats.
Asterisk indicates a significant change as compared to the
value obtained in vehicle-treated animals.  Cross indicates a
significant change as compared to the value obtained in ASA-
treated animals.
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experimental models including ischemia reperfu-
sion [24], stress [23], aspirin and indomethacin
[24]. Our study are in keeping with the previous
observations in experimental animals showing that
NSAID such as ASA and indomethacin are capable
to induce focal ischemia that leads to the enhan-
ced generation of free radicals. ROS may play an
important role in the pathophysiology of acute
ulceration induced by NSAIDs and ischemia-reper-
fusion because the treatment with potent scaven-
gers of free radicals such as superoxide dismutase
(SOD), catalase or dimethyl sulfoxide (DMSO) con-
ferred mucosal protection and significantly redu-
ced the severity of these lesions [25]. In another
study the development of the stress-induced gastric
lesions was accompanied by the rise in the lipid
peroxidation and neutrophil-dependent myelope-
roxidase activity as well as a decrease in nonprote-
in sulfhydryl levels in the gastric mucosa [26].
Since the NSAID-induced gastric damage is neutro-
phil-dependent process [21], the protective action
of these scavengers was attributed to the inhibition
of neutrophil adherence in the microvessels and
their activation. We tested this hypothesis in rats
treated daily with ASA by determination of ROS by
direct chemiluminescence assay in ASA-treated
mucosa and we found that this chemiluminescen-
ce was significantly higher when compared to con-
trol mucosa treated with vehicle. This rise in free
radical production as determined by lucigenin-am-
plified chemiluminescence in gastric mucosa of
ASA-treated rats was completely suppressed by the
addition of vitamin C to ASA. >From this finding,
we conclude that activation of neutrophils seems
to be crucial for the development of ASA damage
and that neutrophils act as a major source of free
radicals in ASA-treated stomach. This notion is sup-
ported by our observation that ulcerogenic proper-
ties of ASA and ASA-induced rise in the free radical
production were remarkably suppressed by addi-
tion of vitamin C to native ASA and by NO-ASA.
It is of interest that ASA produced elevation of pla-
sma IL-1b concentration during ulcer healing while
NO-releasing ASA or the addition of vitamin C to
native ASA failed to alter significantly the plasma
IL-1b levels as compared to vehicle-treated ani-
mals. This indicates that NO-ASA can differ from
native ASA in limitation of inflammatory response
around the ulcer, which is an important event ta-
king place during the prolongation of ulcer healing
by classic NSAID such as ASA.
Experimental evidence suggests that lipid peroxida-
tion on the cell membranes may play a significant
role in ROS-mediated cell injury by the destruction
and damage to cell membranes that consequently
leads to mucosal injury [27]. Lipid peroxidation is
an autocatalytic ROS mediated destructive process
whereby polyunsaturated fatty acids in cell mem-
branes undergo degradation to form lipid hydrope-
roxides. These latter compounds spontaneously re-
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Figure 3. Mean area of gastric ulcers, the gastric blood flow (GBF) at
ulcer margin and plasma IL-1b levels in rats treated with
vehicle (VEH), ASA with or without the combination with
vitamin C (0.5 g/kg — d i.g.) or treated with NO-ASA applied
in a dose of 50 mg/kg — d i.g. Mean–SEM of 6—8 rats.
Asterisk indicates significant change as compared to the
value obtained in vehicle-treated gastric mucosa. Cross
indicates significant change as compared to the values
recorded in ASA-treated animals.
Figure 4. Mean area of gastric ulcers, the gastric blood flow (GBF) at
ulcer margin and gastric malonyldialdehyde (MDA) plus 4-
HNE content in rats treated with vehicle (VEH), ASA with or
without the combination with vitamin C (0. 5 g/kg — d i.g.)
and those treated with NO-ASA applied in a dose of 50
mg/kg — d i.g. Mean–SEM of 6—8 rats. Asterisk indicates
significant change as compared to the value obtained in
vehicle-treated gastric mucosa. Cross indicates significant
change as compared to the values recorded in rats treated
with native ASA.
598
Basic Research
arrange to produce multiple degradation products,
including malondialdehyde (MDA) [28].
It was demonstrated that pretreatment of gastric
mucosa with ROS scavengers such as SOD, DMSO
or taurine exhibited the protective activity against
NSAID-induced gastric mucosal injury due to the
suppression of an increase in thiobarbituric acid-re-
active substances (TBA) measured as an index of li-
pid peroxidation and neutrophil activation [29]. In
the study of Tanaka and Yuda [27], indomethacin
produced an increase in the lipid peroxidation and
markedly decreased the SOD and GSH-x activity
in the gastric mucosa. These authors [27] conclu-
ded that decrease in the SOD and GPx activity
contributes to an increase in lipid peroxidation and
aggravation of the injury induced by free radicals.
In agreement with these studies we have shown,
for the first time, in rats with preexisting gastric
ulcerations that exposure of the rat gastric mucosa
to ASA resulted in the elevation of gastric mucosal
MDA content. This remains in agreement with
experimental evidence in laboratory animals that
severe oxidative stress caused by focal ischemia or
indomethacin is manifested by the excessive lipid
peroxidation and depletion of SOD activity in the
gastric as well as pancreatic tissue [28—30]. Further
studies are needed to clarify whether prolonged
treatment with ASA influences the activity and
expression of potent antioxidizing enzymes such as
SOD and GSH-x during the process of healing of
preexisting gastric ulcers.
In summary, we have demonstrated that ASA pro-
duces an increase in ROS and that this event con-
tributes significantly to the delay in ulcer healing
induced by this NSAID. The increase in free radical
metabolites depends possibly upon neutrophil acti-
vation and is associated with the significant incre-
ase in lipid peroxidation, the fall in the GBF at
ulcer margin and the excessive release of proin-
flammatory cytokine such as IL-1b. This increase in
lipid peroxidation and plasma IL-1b levels as well
as the deleterious effect on the GBF at ulcer mar-
gin were, in part, abolished by topical supplemen-
tation with vitamin C or the treatment with NO-
-ASA suggesting that the treatment with these new
generation of NSAID or vitamin C could limit the
adverse effects such prolongation of ulcer healing
induced of classic NSAID.
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